Advaccine is a biotechnology firm that develops and commercializes vaccines for the prevention and therapeutics of common diseases... Read more
Advaccine is a biotechnology firm that develops and commercializes vaccines for the prevention and therapeutics of common diseases... Read more
CEO
Jane YU
News
Aug 11, 2021
Pharmabiz
Beijing Advaccine Biotechnology: Inovio, Advaccine receive regulatory nod for two heterologous primeboost trials in China using Covid19 DNA vaccine candidate, INO4800
Jun 04, 2021
Markets Insider
Beijing Advaccine Biotechnology: Advaccine Announces First Participants Dosed in Phase 2 Study of ADV110 Evaluating Respiratory Syncytial Virus (RSV) Vaccine Candidate in Australia
Feb 12, 2020
BioPortfolio
Beijing Advaccine Biotechnology: Beijing Advaccine Raises $4.3 Million for Coronavirus Vaccine Development
Feb 01, 2020
Pharmabiz
Advaccine: Inovio, Beijing Advaccine collaborate to develop INO─4800 vaccine against new coronavirus in China